Promore Pharma AB
0
0
+SEK0,00+0% 00:00 Hari ini
Statistik
Tertinggi hari ini
-
Terendah hari ini
-
Tertinggi 52M
-
Terendah 52M
-
Volume
-
Vol. rata2
-
Kap. pasar
0
Rasio P/E
-
Imbal hasil dividen
-
Dividen
-
Pesaing
Daftar ini adalah analisis berdasarkan peristiwa pasar terbaru. Ini bukan rekomendasi investasi.
Tentang
Promore Pharma AB (publ), a biopharmaceutical company, develops peptide-based drug candidates in Sweden and internationally. Its product candidates include PXL01 that is in Phase IIa study for the prevention of post-surgical adhesions and scars, and for the prevention of dermal scars, as well as for tendon repair surgery in the hand; and LL-37, which has completed Phase IIb clinical studies for treating patients with venous leg ulcers, stimulate the healing of chronic wounds, and for the treatment of diabetic foot ulcers. The company was formerly known as Lipopeptide AB and changed its name to Promore Pharma AB (publ) in January 2017. Promore Pharma AB (publ) was founded in 2002 and is headquartered in Solna, Sweden.
Tampilkan lebih banyak
CEO
Dr. Jonas Ekblom Ph.D.
Karyawan
1
Negara
Swedia
ISIN
SE0016074629
Pencatatan
0 Komentar
Bagikan pendapatmu
FAQ
Apa simbol saham Promore Pharma AB?▼
Tergantung pada bursa, simbol saham dapat berbeda. Misalnya, di bursa Stockholm Exchange, saham Promore Pharma AB diperdagangkan dengan simbol PROMO-BTA.ST.
Berapa jumlah karyawan Promore Pharma AB?▼
Per 2 November 2026, perusahaan memiliki 1 karyawan.
Promore Pharma AB berada di sektor apa?▼
Promore Pharma AB beroperasi di sektor Kesehatan & Kebugaran.
Kapan Promore Pharma AB menyelesaikan split saham?▼
Promore Pharma AB belum melakukan split saham baru-baru ini.
Di mana kantor pusat Promore Pharma AB?▼
Kantor pusat Promore Pharma AB berlokasi di Solna, Swedia.